India’s Pharma Exports to Cross $30 Billion; Domestic Market to Double by 2030

India’s pharmaceutical exports, presently valued at nearly $27.8 billion, are poised to cross $30 billion by the end of 2025. With a robust domestic market and rising MedTech innovation, India is strengthening its status as a global leader in affordable healthcare solutions.

Pharma and Biotech Sectors Witness Record Growth

Union Minister Dr Jitendra Singh announced that India's pharma exports are projected to surpass $30 billion by December 2025. The domestic pharma market, currently worth $60 billion, is anticipated to touch $130 billion by 2030. This surge is backed by strong government initiatives, increasing innovation, and rapid ecosystem expansion.

MedTech Sector Registers 15 to 20% Annual Growth

India’s MedTech sector is expanding at an impressive rate of 15% to 20% annually. With around 800 medical device manufacturers in the country, the growing demand for healthcare technology and equipment is significantly contributing to export potential and job creation in the sector.

Centre-State Collaboration Boosts Innovation

A new Memorandum of Understanding (MoU) between the Department of Biotechnology (DBT) and the Uttar Pradesh government aims to strengthen pharma, biotech, and MedTech innovation. The partnership will focus on startup incubation, R&D, and technology commercialisation to scale affordable healthcare solutions nationwide.

Read More: Lupin Arm Ink Agreement to Acquire VISUfarma for €190 Million; Share Price Surges!

India Emerges as Global Vaccine Supplier

India now manufactures more than 60% of the world’s vaccines, supplying to over 200 countries. The country’s bioeconomy has reached a valuation of $165 billion, highlighting its critical role in global health systems and vaccine accessibility.

Startups and Centres of Excellence Take Lead

With growth from just 50 startups in 2014 to over 11,000 in 2025, India’s biotech momentum reflects its commitment to healthcare transformation. Projects like the Biotech Park in Lucknow and the Medical Device Park in Greater Noida are set to become innovation powerhouses.

Conclusion

Driven by strong policy frameworks and dynamic partnerships, India’s pharma sector is on track to exceed $30 billion in exports by the end of 2025. The biotech and MedTech sectors further enhance this outlook, reinforcing India’s dominance in affordable, high-impact healthcare technologies.

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in securities are subject to market risks. Read all related documents carefully before investing.